CRINETICS PHARMACEUTICALS IN
CRNXNASDAQ🏆 #898 by market capEarnings Nov 5US Equity
$84.49▲ $0.13 (+0.15%)
Live1h▲ 0.0%
24h▲ 0.1%
7d▲ 0.6%
14d▲ 0.8%
30d▲ 1.0%
1y▲ 196.2%
🏦Market Cap
$8.95B
Small Cap
📈Revenue Growth (YoY)
+640.7%
High Growth
📊Gross Margin
99.2%
High
💵FCF Margin
-1008.6%
Thin
⚖️P/S Ratio
212.4x
Expensive
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-03Earnings Per Share
Actual
-1.14
Expected
-1.18
beat
+3.40%
YoY +7.30%
Revenue
Actual
$25.12M
Expected
$14.84M
beat
+69.20%
YoY +2336.30%
Consensus estimates
Recent quarters
Q3 2026
-1.14
beat
Q2 2026
-1.23
miss
Q1 2026
-1.29
beat
Q4 2025
-1.38
miss